SightfileU.S. market data from official filings

CRINETICS PHARMACEUTICALS IN (CRNX)

Name: CRINETICS PHARMACEUTICALS IN (CRNX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001658247 · EDGAR filings · Updated 2026-07-21

CRINETICS PHARMACEUTICALS IN (CRNX) has reported institutional ownership of 116.4%, with 242 institutional managers holding positions valued at $4.46B per the latest 13F reporting period.

Institutional ownership

116.4%

Institutional managers

242

Reported 13F value

$4.46B

Insider activity

48 trans.

−$8.24M net selling

Latest updates

2026-07-21 — PREM14A filed
2026-07-10 — DEFA14A filed
2026-07-10 — Current report (8-K) filed
2026-07-07 — Insider transaction reported (Form 4)
2026-07-06 — DEFA14A filed
2026-07-06 — DEFA14A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CRINETICS PHARMACEUTICALS IN has 242 institutional holders and institutional ownership of 116.4%.

Insider activity

Insiders reported 48 transactions (0 buys, 21 sells) across 13 reporting insiders, with a net reported value of −$8.24M.

Related companies

CHEMED CORP NEW (CHE) · BRUKER CORP COM (BRKR) · ENVISTA HOLDINGS CORPORATION (NVST) · OPTION CARE HEALTH INC (OPCH) · ERASCA INC (ERAS) · RADNET INC (RDNT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.